High-resolution HLA alleles and haplotypes in the United States population
Introduction
Progress in the discovery of new allelic variability in the histocompatibility loci, with up to hundreds of alleles defined at individual HLA loci, is evident [1], yet an accurate and statistically adequate characterization of the distribution of this variation at the population level has been lagging. Knowledge of HLA data at the level of a specific population or ethnic group level is especially important because of the considerable differentiation in HLA frequencies that has occurred among human populations since our species’ first appearance and subsequent spread across Africa and other continents. The International HLA Workshop Anthropology components have played a very useful role in defining HLA polymorphism at the population level with surveys of HLA variation across a variety of human populations [2]. The sample sizes in these studies have been sufficient to sketch the broad outlines of the dominant HLA specificities and haplotypes present in a group. In contrast the value of a full picture of HLA variation for a given human population gained from samples sufficient for a complete and thorough characterization of the genetic diversity of HLA has a number of important applications which are not possible from studies involving less thorough typing and less sampling. We mention here the daily utility accrued from such information in ascertaining potential patient matches from a donor registry, the background information essential to determining the development of optimal donor registry size according to ethnic group, and the degree of HLA differentiation at the population level accrued during the course of human population evolution.
The National Marrow Donor Program (NMDP) has the mission of developing, maintaining and coordinating a repository of HLA-typed donors to facilitate hematopoietic stem cell transplantation among unrelated individuals in the United States. To this end a donor pool of several million individuals has been developed for which HLA typing has been performed (www.marrow.org). We have extracted the existing high-resolution HLA typings from the NMDP databanks and present this information according to the broad ethnic classifications of individuals in the United States defined by the United States census. The census categories themselves are only rough and sometimes poor categorization of original geographically based human ethnicities. In addition, the NMDP HLA high-resolution typings can stray from a random sample of even the census population categories. Nonetheless, we feel that this set of HLA population based frequency data can prove extremely valuable at this time. The large sizes of the available population samples and the uniform consistency and quality control procedures employed in the HLA typing make this data a unique resource.
Section snippets
Subjects and methods
The samples used in this analysis are from two NMDP sources: (1) prospective high-resolution (SBT-based) typing for the three minority population samples, and (2) donors from donor–recipient pairs typed at high resolution (SBT-, SSOP-, or SSP-based) for the European American sample. The minority prospective high-resolution typing was performed by quality-controlled NMDP contract laboratories and all data was validated against prior typings. The donor–recipient pair donor typing was subjected to
Results
HLA frequency data are presented on the basis of the four predominant US census categories for categorizing ethnic and racial groups: African Americans, Asians (Asians and Pacific Islanders), European Americans (white, or Caucasian) and Hispanics. These categories from NMDP input questionnaires define the self-described ethnic groups. High resolution HLA allele frequency data on the five most commonly typed loci (A, C, B, DRB1, and DQB1) and 10 haplotype categories (including two-, three-,
Discussion
Well-defined samples of HLA data for populations, such as those presented in this report, have several strengths. While many population-based reports of HLA typings have been published, these have not been uniformly consistent in mode and thoroughness of HLA typing methodologies and number of loci included, nor have they been conducted with sample sizes adequate for a statistically complete characterization of the variation present. The combination of these inadequacies in currently available
Acknowledgments
We are indebted to the network of NMDP contract laboratories that have performed HLA typing used in this study. American Red Cross National Histocompatibility Laboratory (Marcelo Fernandez-Vina, Ph.D.), American Red Cross New England Region (Marcela Saluzar, M.D, Neng Yu, M.D.), American Red Cross Penn-Jersey Region (Susan Hsu, Ph.D.), Children’s Hospital Oakland Research Institute (Elizabeth Trachtenberg, Ph.D.), Dana-Farber Cancer Institute (Edmond Yunis, M.D.), Histogenetics, Inc. (Soo Young
References (17)
WHO Nomenclature Committee for Factors of the HLA SystemNomenclature for Factors of the HLA System, Update March 2006
Hum Immunol
(2006)- et al.
HLA-A, -B and -Cw allele frequencies in an Asian population from the USA
Hum Immunol
(2004) - et al.
Accuracy of haplotype frequency estimation for biallelic loci, via the expectation-maximization algorithm for unphased diploid genotype data
Am J Hum Genet
(2000) - et al.
Charting the ancestry of African Americans
Am J Hum Genet
(2005) - et al.
Estimating African American admixture proportions by use of population-specific alleles
Am J Hum Genet
(1998) - et al.
New HLA haplotype frequency reference standards: High-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans
Tissue Antigens
(2003) - et al.
Common and well-documented HLA alleles
Hum Immunol
(2007)
Cited by (369)
Shared graft-versus-leukemia minor histocompatibility antigens in DISCOVeRY-BMT
2023, Blood AdvancesCancer Immunotherapy Beyond Checkpoint Blockade: JACC: CardioOncology State-of-the-Art Review
2022, JACC: CardioOncologyHLA-class II restricted TCR targeting human papillomavirus type 18 E7 induces solid tumor remission in mice
2024, Nature Communications